跳至主要内容
临床试验/NCT05297032
NCT05297032终止不适用

Evaluation of a Computational Model That Predicts the Effects of Quercetin on Metabolic Health Using Biological Age and Other Lipid-related Blood Metrics

Thorne HealthTech, Inc2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2022年3月24日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
5
试验地点
2
主要终点
Change in Apolipoprotein B from before (day 0) to after (day 90) supplementation

研究概览

简要总结

Quercetin is a natural flavonoid compound widely found in vegetables, fruits, and nuts. It has a long history of use as a dietary supplement. This study aims to assess results from a computational model suggesting that quercetin may offer novel benefits to metabolic health. Participants will take quercetin (as Quercetin Phytosome, a proprietary formulation with enhanced absorption properties) for 90 days while keeping lifestyle habits consistent throughout to estimate net effects of quercetin as much as possible. Blood samples will be collected at the beginning and end of the study to assess the effects of quercetin supplementation on metabolic health metrics such as LDL cholesterol, blood sugar, liver, kidney and immune function and calculated metabolic age. In addition, questionnaires will be completed to ensure compliance with study requirements and assess potential quercetin benefits in the participants' quality of life. This work will provide a proof-of-concept from a computational model of nutraceutical compounds and proposes a new application of quercetin in support of healthy human metabolism.

详细描述

Following intake and enrollment steps, including providing consent, and approximately one week before other study activities begin, participants will submit an online questionnaire to collect baseline data about lifestyle factors such as diet, exercise, sleep, stress, and general quality of life. During this period they will also receive the study supplement and schedule their first blood draw at a local-to-them Quest Diagnostics facility. Participants will begin taking the study supplement on the day after their first blood draw. Study dosing consists of one capsule of Quercetin Phytosome (Thorne Research, Inc.; 250 mg) taken three times per day with meals for 90 days. Approximately one week after beginning to take study doses, and bi-weekly thereafter, participants will complete an online questionnaire to monitor lifestyle and quality of life factors. The final questionnaire will be completed on the day of or the day after the last study dose is taken. The day after the last study dose, participants will complete a second blood draw at Quest Diagnostics.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 20-70 years
  • Self-report that, within the past 6 months, a medical professional has informed them of, or a blood test result has shown high-healthy Low Density Lipoprotein (LDL) levels (preferred range, if known: 130-159 mg/dL)
  • AND 2 or more of the following 4 (values are preferred, if known):
  • Low-healthy fasting High Density Lipoprotein (HDL < 50 mg/dL)
  • High-healthy fasting Triglycerides (TG 150-199 mg/dL)
  • High-healthy fasting Blood Sugar (Glucose 100-126 mg/dL)
  • Waist Circumference > 40 in for men or > 35 in for women (this may be self-measured)
  • Willing and able to travel to a Quest location for both blood draws
  • Willing and able to fast (except water) for 12 hours prior to each blood draw
  • Willing and able to comply with the study schedule (+/- 2 days)
  • Willing and able to complete online questionnaires
  • Willing and able to check email for study-related messages regularly (daily) and to use email as the primary means of communication for non-emergency study-related contact with the study team
  • Informed consent to participate in the study discussed and signed
  • Willing and able to avoid making changes to diet, sleep, stress, exercise, and other lifestyle factors that may influence the study metrics
  • Willing and able to avoid use of the following supplements during the study:
  • Quercetin, Berberine, Red Yeast Rice, Fish Oil, Bergamot Juice Extract, Pantethine, Vitamin D3 dosing over 5,000IU daily, Pterostilbene, Aged Garlic, Phytosterols, Niacin (crystalline/acid, not niacinamide), Meriva/curcumin/turmeric

排除标准

  • Individuals who live in NY, NJ, RI, SD, ND, HI, or MD (due to lack of availability of WellnessFX or Quest services)
  • Individuals who are currently taking any lipid-lowering medications (including statins) or have taken them within the past 6 months.
  • Individuals who are currently taking or have taken any lipid-lowering supplements (including quercetin) consistently in the past 4 weeks. Excluded supplements are products that contain:
  • o Berberine, Red Yeast Rice, Fish Oil, Bergamot Juice Extract, Pantethine, Vitamin D3 dosing over 5,000IU daily, Pterostilbene, Aged Garlic, Phytosterols, Niacin (crystalline/acid, not niacinamide), Meriva/curcumin/turmeric
  • Diagnosed with metabolic syndrome
  • Being treated for hypertension
  • Known allergy or sensitivity to any components of the trial's nutritional supplement
  • Myocardial infarction, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, or stent within five years
  • Known clinical coronary heart disease symptoms
  • Known clinical angina
  • History of cerebrovascular accident
  • Creatinine > 2.5 mg/dL
  • Chronic liver disease with AST, ALT, or alkaline phosphatase over 1.5 times normal
  • Known cancer within two years
  • Clinical congestive heart failure (systolic or diastolic CHF)
  • Type 1 or type 2 diabetes mellitus
  • Habitual drinking (cutoff at PI discretion using the following guidelines: 8 or more drinks a week) or being a current smoker/vaping
  • Pregnant or nursing
  • Women of child-bearing age not using an approved contraceptive
  • Planned major surgery during the study (1 week before first blood draw and during the 90-day supplementation)

结局指标

主要结局

Change in Apolipoprotein B from before (day 0) to after (day 90) supplementation

时间窗: 90 days

Quantitative changes before and after intervention in Apolipoprotein B test (Quest Diagnostics 91726) (Scale: mg/dL)

Change in Lipoprotein Fractions from before (day 0) to after (day 90) supplementation

时间窗: 90 days

Quantitative changes before and after intervention in Lipoprotein Fractionation, Ion Mobility test (Quest Diagnostics 91604) (Scale: particle number)

Quality of Life scale changes from before (day 0) to after (day 90) supplementation

时间窗: 90 days

Quantitative changes in The Quality of Life Scale (Scale: 1-100 as determined by ref: http://www.jstor.org/stable/4034400)

Change in Biological Age score from before (day 0) to after (day 90) supplementation

时间窗: 90 days

Quantitative changes before and after intervention in calculated metrics of biological age. These metrics are calculated by applying the Klemera-Doubal algorithm to a proprietary set of clinical measures. (Scale for each metric: 0-120) (ref: https://academic.oup.com/biomedgerontology/article/74/Supplement\_1/S52/5625183?login=true)

次要结局

  • Lifestyle changes from before (day 0) to after (day 90) supplementation(90 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验